Cargando…
Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β
BACKGROUND: Surfactant protein D (SP-D) can regulate both innate and adaptive immunity. Recently, SP-D has been shown to contribute to the pathogenesis of airway allergic inflammation and bleomycin-induced pulmonary fibrosis. However, in allergic airways disease, the role of SP-D in airway remodelin...
Autores principales: | Ogawa, Hirohisa, Ledford, Julie G, Mukherjee, Sambuddho, Aono, Yoshinori, Nishioka, Yasuhiko, Lee, James J, Izumi, Keisuke, Hollingsworth, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262976/ https://www.ncbi.nlm.nih.gov/pubmed/25472740 http://dx.doi.org/10.1186/s12931-014-0143-9 |
Ejemplares similares
-
Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic Lungs
por: Ledford, Julie G., et al.
Publicado: (2012) -
IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators
por: Tezuka, Toshifumi, et al.
Publicado: (2015) -
The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-β production in regulatory T-cells
por: Kagawa, Kozo, et al.
Publicado: (2022) -
Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice
por: Kishi, Masami, et al.
Publicado: (2018) -
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017)